Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Milk or colostrum
Reexamination Certificate
2011-07-05
2011-07-05
Ford, Vanessa L. (Department: 1645)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Milk or colostrum
C424S157100, C424S278100, C424S184100
Reexamination Certificate
active
07972629
ABSTRACT:
The present invention relates to use of a milk apoprotein or a mixture thereof to prevent or treat microbial or viral infection of the human or animal body. It is believed that this is achieved by inhibiting adhesion of potential pathogens. More preferably, at least one milk apoprotein or a mixture thereof is administered, simultaneously or sequentially, with either or both of at least one free fatty acid or a mixture thereof or a monoglyceride thereof; and/or at least one organic acid or a salt or ester thereof or a mixture thereof. The active agent(s) may be delivered by means of a pharmaceutically acceptable delivery system which includes parenteral solutions, ointments, eye drops, nasal sprays, intravaginal devices, surgical dressings, medical foods or drinks, oral healthcare formulations and medicaments for mucosal applications.
REFERENCES:
patent: 2796378 (1957-06-01), Ferguson, Jr.
patent: 4397927 (1983-08-01), Brog
patent: 4918008 (1990-04-01), Gauri
patent: 5160759 (1992-11-01), Nomura et al.
patent: 5667797 (1997-09-01), Peterson et al.
patent: 5785984 (1998-07-01), Kurihara et al.
patent: 6287590 (2001-09-01), Dasseux
patent: 6319895 (2001-11-01), Tomita et al.
patent: 6468556 (2002-10-01), Noda et al.
patent: 6764707 (2004-07-01), Masui et al.
patent: 2001/0007690 (2001-07-01), Girsh
patent: 2003/0031758 (2003-02-01), Koss et al.
patent: 2003/0165606 (2003-09-01), Lasekan et al.
patent: 0572139 (1993-12-01), None
patent: 1319407 (2003-06-01), None
patent: 1050756 (1966-12-01), None
patent: 62-249931 (1987-10-01), None
patent: 03-220130 (1991-09-01), None
patent: 04-159232 (1992-06-01), None
patent: 10-059865 (1998-03-01), None
patent: 8604217 (1986-07-01), None
patent: 9604929 (1996-02-01), None
patent: 9904804 (1999-02-01), None
patent: 9926971 (1999-06-01), None
patent: 0000214 (2000-01-01), None
patent: 0048558 (2000-08-01), None
Clerici et al. (Exp. Opin. Invest. Drugs, 1999; 8(2): 95-106).
DeMets (Chlamydia trachomatis, Bacteriology at UW-Madison 330 Lecture Topic, http://www.bact.wisc.edu/bact330/lecturechlamydia, pp. 1-7; Aug. 2005).
Deepe (Clinical Microbiology Reviews, 1997; 10(4): 585-96).
Sprong C et al.: “Bacterial Activities of Milk Lipids”, Antimicrobial Agents of Chemotherapy, vol. 45, No. 4, Apr. 2001, pp. 1298-1301, XP002235259 cited in the application Abstract.
Kanno et al., “Selective solubilisation of glycoproteins of milk fat globule membrane with KCI and MgCI2”, Agric. Biol. Chem., 1980; 44(5); 1193-94.
Maruyama et al., “The effect of milk and skim milk intake on serum lipids and apoproteins in postmenopausal females”, J. Nutr. Sci. Vitaminol., 1992; 38: 203-213.
Biervliet et al., “Serum cholesterol, cholesteryl ester and high-density lipoprotein development in newborn infants: response to formulas supplemented with cholesterol and gamma-linolenic acid”, J. Pediatr., 1992: 120: S101-8.
Satoh et al., “Repression of fat-dependent intestinal Apo A-IV mRNA abundance by medium chain triacylgycerols and proteins and elevation by carbohydrates of fat-dependent Apo A-IV transport in suckling rat pups”, J. Nutr. Sci. Vitaminol, 1995; 41: 293-306.
Wikipedia (http://en.wikipedia.org/wiki/whey—protein)—definition of whey protein.
http://www.healthscout.com/ency/68/312/main.html#PreventionofCandidaAlbicans; accessed Sep. 12, 2007.
Ellis, R, New Technologies for Making Vaccines, text book, 1998, pp. 568-575.
Boslego, J. et al., Gonorrhea Vaccines, 1988, Chapter 17, pp. 211-223.
Freshney, Culture of Animal Cells, A Manual of Basic Technique, Alar R. Liss, Inc., 1983, New York, p. 4.
Dermer, Bio/Technology, 1994, vol. 12, p. 320.
Fujimoto et al., J. Clin. Invest, 1993; 91: 1830-1833.
Nonnecke, B.J. et al., “Inhibition of mastic bacteria by bovine milk-apo-lactoferrin evaluated by in vitro microassay of bacterial growth”, J. Dairy Sci., 1984, vol. 67, No. 3, p. 606-613.
Brady Damien
Folan Michael A.
Ford Vanessa L.
Kimble Karen L.
Technology Law, PLLC.
Tongue Lakia
Westgate Biological Ltd.
LandOfFree
Product comprising a combination of milk serum apoproteins... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Product comprising a combination of milk serum apoproteins..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Product comprising a combination of milk serum apoproteins... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2659227